EUVIMEDEUVIMED entdecken
Open Access

Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes

Yu Wang iD, Ping Zhang iD, Xilin Zhou, Deborah Rolka, Giuseppina Imperatore

Diabetes Care · 2024

DOI: 10.2337/dc23-1679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, 2024. Verfasst von Yu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To compare total and out-of-pocket (OOP) medical expenditures between pre–COVID-19 (March 2019 to February 2020) and COVID-19 (March 2020 to February 2022) periods among Medicare beneficiaries with diabetes. RESEARCH DESIGN AND METHODS Data were from 100% Medicare fee-for-service claims. Diabetes was identified using ICD-10 codes. We calculated quarterly total and OOP medical expenditures at the population and per capita level in total and by service type. Per capita expenditures were calculated by dividing the population expenditure by the number of beneficiaries with diabetes in the same quarter. Changes in expenditures were calculated as the differences in the same quarters between the prepandemic and pandemic years. RESULTS Population total expenditure fell to $33.6 billion in the 1st quarter of the pandemic from $41.7 billion in the same prepandemic quarter; it then bounced back to $36.8 billion by the 4th quarter of the 2nd pandemic year. The per capita total expenditure fell to $5,356 in the 1st quarter of the pandemic from $6,500 in the same prepandemic quarter. It then increased to $6,096 by the 4th quarter of the 2nd pandemic year, surpassing the same quarter in the prepandemic year ($5,982). Both population and per capita OOP expenditures during the pandemic period were lower than the prepandemic period. Changes in per capita expenditure between the pre–COVID-19 and COVID-19 periods by service type varied. CONCLUSIONS COVID-19 had a significant impact on both total and per capita medical expenditures among Medicare beneficiaries with diabetes. The COVID-19 pandemic was associated with lower OOP expenditures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Diabetes MellitusAgedHumansUnited StatesMedicareHealth ExpendituresPandemicsFee-for-Service Plans

Autor:innen und Institutionen

  • Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA.

ORCID-Profile: Yu Wang, Ping Zhang

Förderung

  • Intramural CDC HHS

Zitieren

APA

Wang, Y., Zhang, P., Zhou, X., Rolka, D., & Imperatore, G. (2024). Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes. Diabetes Care. https://doi.org/10.2337/dc23-1679

Vancouver

Wang Y, Zhang P, Zhou X, Rolka D, Imperatore G. Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes. Diabetes Care. 2024. doi:10.2337/dc23-1679

BibTeX
@article{Wang2024,
  author = {Wang, Yu and Zhang, Ping and Zhou, Xilin and Rolka, Deborah and Imperatore, Giuseppina},
  title = {Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes},
  journal = {Diabetes Care},
  year = {2024},
  doi = {10.2337/dc23-1679}
}
Kostenlos starten →